3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Recurrence
3
Neoplasms, Plasma Cell
3
Immunoglobulin Light-chain Amyloidosis
2
Amyloidosis
2
Interventions
Etoposide
3
daratumumab
2
Vincristine
2
Prednisone
2
Doxorubicin
2
Cyclophosphamide
2
varlilumab
1
prednylidene
1
pomalidomide
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Specimen Handling
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Disulfides
1
Dexamethasone
1
Cytarabine
1
Carmustine
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Plasmablastic Lymphoma
×
belantamab mafodotin
×
90 days
×
Clear all
No trials found.